NEWS and OPINIONS
Charles River jumps into cell and gene therapy manufacturing with $875M Cognate buy
By Fraiser Kansteiner - Fierce Pharma Just a few weeks after Cognate BioServices moved to beef up its cell and gene therapy manufacturing, the company has attracted a buyer eager to tap that expertise. Charles River Laboratories agreed to throw down $875 million cash...
Vertex absorbs ViaCyte and its stem cell-based diabetes treatment for $320M, clearing out competition
By Max Bayer - Fierce Pharma Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from an FDA clinical hold, the company is clearing out potential competition by buying ViaCyte for $320 million. The all-cash deal announced Monday throws a...
A major step forward for organ biofabrication
By recreating the helical structure of heart muscles, researchers improve understanding of how the heart beats By Leah Burrows - Harvard John A Paulson School of Engineering and Applied Sciences Heart disease — the leading cause of death in the U.S. — is so deadly in...
A Newly Discovered Type of Stem Cell Could Allow Scientists To Make Organs in a Dish
By University of Copenhagen - SciTechDaily.com The University of Copenhagen researchers utilized a mouse model to discover an alternate path that some cells follow to build organs and used that information to exploit a new kind of stem cells as a possible supply of...
New study allows researchers to more efficiently form human heart cells from stem cells
By Rebekah McBride - University of Wisconsin–Madison Lab-grown human heart cells provide a powerful tool to understand and potentially treat heart disease. However, the methods to produce human heart cells from pluripotent stem cells are not optimal. Fortunately, a...
UPDATE: Convicted Italian Surgeon Gets Sentence Appealed in High-Profile Case
Swedish prosecutors have appealed a sentence given to an Italian surgeon who was prosecuted for causing bodily harm during experimental stem-cell windpipe transplants By AP COPENHAGEN, Denmark (AP) - Swedish prosecutors on Wednesday appealed a sentence given to an...
Scientists Find A Multidimensional Universe Inside the Human Brain
"Algebra, much less "algebraic topology", was never my strong suit. However, reading this fascinating article definitely stimulated the 11 dimensions in my aging lawyer's brain! According to a study published in "Frontiers in Computational Neuroscience", the...
Mayo Clinic – Bringing Regenerative Technology of the Future to Patients Today
By Susan Buckles "The sky's the limit," "possibility" and "potential cure for disease" are aspirational ways Mayo Clinic physicians and scientists described regenerative medicine in a recent virtual presentation at the World Stem Cell Summit 2022. Mayo's panel...
Hair Loss Treatment Uses Stem Cells to Generate Healthy New Follicles
By Gail Dutton - Genetic Engineering and Biotechnology News Stemson Therapeutics is harvesting patient cells, generating and differentiating iPSCs, and pro-ducing dermal papilla cells in abundance Hair loss can be distressing, even devastating, but it isn’t considered...
:format(webp)/cdn.vox-cdn.com/uploads/chorus_image/image/70912912/Image_4.0.jpg "Scientists grow cells on a robot skeleton (but don’t know what to do with them yet)")
Scientists grow cells on a robot skeleton (but don’t know what to do with them yet)
A new method of tissue engineering is only a proof of concept for now By James Vincent - The Verge The science of tissue engineering — or growing human cells for use in medicine — is very much in its infancy, with only the simplest lab-grown cells able to be used in...
Penn Medicine Developed CAR T Cell Therapy Wins Third FDA Approval
PHILADELPHIA – The U.S. Food and Drug Administration (FDA) has expanded its approval for a personalized cellular therapy developed at the University of Pennsylvania’s Abramson Cancer Center, this time for the treatment of adults with relapsed or refractory follicular...
How do you expand cell therapy manufacturing to reach more patients per year?
By Jane Byrne BioPharma-Reporter The potential of cell therapy is proven, but its impact is limited by manufacturing bottlenecks. “There is broad consensus that we need to automate and quickly in order for cell therapy manufacturing to become a viable industry,...